Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
61.50
+0.70 (1.15%)
Aug 27, 2026, 5:35 PM CET

BME:ROVI Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
185.18140.44136.88170.34199.67153.08
Depreciation & Amortization
31.6628.7626.9223.4421.8420.3
Other Amortization
1.941.621.090.91.031.06
Loss (Gain) From Sale of Assets
1.780.014.39---
Loss (Gain) From Sale of Investments
0.020.51-0.080.22-1.83-1.16
Loss (Gain) on Equity Investments
-0.22-0.060.140.13-0.2-0.18
Stock-Based Compensation
-----1.4
Provision & Write-off of Bad Debts
-0.31-0.31-7.97-0.040.04-0.27
Other Operating Activities
-23.711.55-32.06-47.2874.0339.24
Change in Accounts Receivable
-23.74-30.1913.4119.47-26.82-74.19
Change in Inventory
53.1342.9911.87-29.29-71.59-23.43
Change in Accounts Payable
27.07-7.75-16.36-23.9241.6735.36
Change in Other Net Operating Assets
0.49-0.50.04-0.7-0.23-1.78
Operating Cash Flow
253.32187.08138.28113.25237.6149.44
Operating Cash Flow Growth
85.51%35.29%22.10%-52.34%58.99%218.80%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-73.93-65.21-59.12-53.79-50.72-40.22
Sale of Property, Plant & Equipment
0.060.140.040.380.080.03
Sale (Purchase) of Intangibles
-3.47-2.6-3.1-1.39-0.67-0.72
Investment in Securities
-24.13-3.46-19.011.29-5.85-
Other Investing Activities
1.232.660.131.490.010.07
Investing Cash Flow
-100.25-68.48-81.06-52.03-57.15-40.84

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-47.6196.950.731.41.34
Long-Term Debt Repaid
--46.79-51.71-13.65-6.77-6.19
Net Debt Issued (Repaid)
-27.620.8245.24-12.92-5.37-4.85
Issuance of Common Stock
64.1354.8541.9252.6477.7742.33
Repurchase of Common Stock
-65.75-54.86-89.71-133.9-177.01-78.79
Common Dividends Paid
-47.83-47.83-56.45-69.05-51.01-21.13
Other Financing Activities
4.71-0.793.642.391.08-0.29
Financing Cash Flow
-72.35-47.81-55.36-160.84-154.54-62.73

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
80.8670.791.86-99.6225.9145.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
179.39121.8779.1659.45186.88109.22
Free Cash Flow Growth
138.23%53.95%33.15%-68.19%71.10%1348.77%
Free Cash Flow Margin
23.21%16.39%10.37%7.17%22.86%16.84%
Free Cash Flow Per Share
3.512.381.551.123.501.97
Levered Free Cash Flow
167.5482.344.8525.36135.9266.2
Unlevered Free Cash Flow
170.0383.946.0925.95136.4566.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.352.31.770.390.290.29
Cash Income Tax Paid
38.4441.9344.2340.8643.8923.86
Change in Working Capital
56.954.558.96-34.45-56.97-64.03